BD FACSDiscover� S8 Cell Sorter

Description

Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations (OLAO) For: National Institute of Dental and Craniofacial Research (NIDCR) Division of Intramural Research (DIR) Combined Technical Research Core (CTRC) 2. Action Being Announced This is a notice of intent, and not a request for competitive quotations, proposals, or bids. The National Institutes of Health (NIH), on behalf of the National Institute of Dental and Craniofacial Research (NIDCR), intends to negotiate and award a firm-fixed-price sole source contract to: Becton, Dickinson and Company / BD Biosciences for the acquisition of one (1) BD FACSDiscover� S8 Cell Sorter, including required configuration, delivery, installation, biosafety-compliant hood, and standard warranty coverage. Project Number: PCA-NIDCR-01222 Project Title: BD FACSDiscover� S8 Cell Sorter 3. Statutory Authority The Government intends to award this requirement on a sole source basis pursuant to: 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements; and as applicable to this acquisition, 41 U.S.C. 1901 and FAR 13.501(a)(1)(ii). This requirement will be processed as an open-market acquisition. 4. Description of Requirement The National Institute of Dental and Craniofacial Research (NIDCR), Division of Intramural Research (DIR), Combined Technical Research Core (CTRC), requires the acquisition of a highly specialized commercial laboratory instrument to replace aging and end-of-life cell sorting instruments and to provide advanced capabilities necessary to support current and future NIH intramural research. The required instrument must provide, at a minimum, the following capabilities: Cell sorting capability for high-parameter research applications; Spectral flow cytometry capability; Integrated real-time imaging during acquisition and/or sorting; Ability to analyze and sort cells based on fluorescence/spectral signatures, morphology, and image-derived parameters; Support for rare-cell sorting; Support for index sorting and plate sorting; and A biosafety-compliant configuration suitable for sorting human cells in NIH research environments. The anticipated delivery period is 60 to 90 days after award for delivery, installation, and acceptance. The acquisition includes a one-year warranty following installation and acceptance.